Art

J-GLOBAL ID：201802248171945088   Reference number：18A1141261

Recent advances of bispecific antibodies in solid tumors

固形腫瘍における二重特異抗体の最近の進歩【JST・京大機械翻訳】

Author (9)： Yu Shengnan (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) ,  Li Anping (Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China) ,  Liu Qian (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) ,  Yuan Xun (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) ,  Xu Hanxiao (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China) ,  Jiao Dechao (Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China) ,  Pestell Richard G. (Pennsylvania Center for Cancer and Regenerative Medicine, Wynnewood, USA) ,  Han Xinwei (Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China) ,  Wu Kongming (Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China)
Material： Journal of Hematology & Oncology (Web)
Volume： 10  Issue： 1  Page： 155  Publication year： 2017 
JST Material Number： U7517A  ISSN： 1756-8722  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Cancer immunotherapy is the mo...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1141261&from=J-GLOBAL&jstjournalNo=U7517A") }}

Thesaurus term： *solid tumor ,  human(primates) ,  clinical trial ,  CEA ,  T cell ,  immunoglobulin G ,  EGF receptor ,  tumor cell ,  therapy
Semi thesaurus term： 臨床応用 ,  遮断 ,  チェックポイント ,  癌治療 ,  癌免疫療法 ,  *特異抗体 , 【Automatic Indexing@JST】

Author keywords (7)： BsAb ,  Solid tumor ,  EpCAM ,  CEA ,  PSMA ,  HER family ,  Radioimmunotherapy

JST classification (2)： Immunotherapy for tumors  (GE03035B) ,  Tumor immunity  (ED03040A)

Reference (155)：

• Nature; Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors; Y Jia, CH Yun, E Park, D Ercan, M Manuia, J Juarez; 534; 7605; 2016; 129-132; 10.1038/nature17960; CR1;
• J Hematol Oncol; Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future; G Goel, W Sun; 8; 2015; 44; 10.1186/s13045-015-0141-5; CR2;
• J Hematol Oncol; Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy; W Ma, BM Gilligan, J Yuan, T Li; 9; 1; 2016; 47; 10.1186/s13045-016-0277-y; CR3;
• J Hematol Oncol; Advances in the management of gastrointestinal cancers-an upcoming role of immune checkpoint blockade; G Goel, W Sun; 8; 2015; 86; 10.1186/s13045-015-0185-6; CR4;
• J Hematol Oncol; High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy; L Falchi, A Sawas, C Deng, JE Amengual, DS Colbourn, EA Lichtenstein; 9; 1; 2016; 132; 10.1186/s13045-016-0363-1; CR5;

Terms in the title (2)： 固形腫瘍 ,  特異抗体